584 related articles for article (PubMed ID: 24943832)
41. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
Jelloul FZ; Yang R; Garces S; Kanagal-Shamanna R; Ok CY; Loghavi S; Routbort MJ; Zuo Z; Yin CC; Floyd K; Bassett RL; Wierda W; Jain N; Thompson P; Luthra R; Medeiros LJ; Patel KP
Leuk Res; 2022 May; 116():106827. PubMed ID: 35430388
[TBL] [Abstract][Full Text] [Related]
42. Novel prognostic molecular factors: a quantum leap in the field of chronic lymphocytic leukemia.
Zakrzewska E; Pirog M; Purkot J; Giannopoulos K
Folia Histochem Cytobiol; 2017; 55(3):95-106. PubMed ID: 28994094
[TBL] [Abstract][Full Text] [Related]
43. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.
Rossi D; Rasi S; Spina V; Fangazio M; Monti S; Greco M; Ciardullo C; Famà R; Cresta S; Bruscaggin A; Laurenti L; Martini M; Musto P; Forconi F; Marasca R; Larocca LM; Foà R; Gaidano G
Br J Haematol; 2012 Aug; 158(3):426-9. PubMed ID: 22571487
[No Abstract] [Full Text] [Related]
44. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
45. SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
Mitsui T; Koiso H; Nakahashi H; Saitoh A; Shimizu H; Ishizaki T; Ogawa Y; Takizawa M; Yokohama A; Saitoh T; Jinbo T; Ogura H; Handa H; Sawamura M; Sakura T; Karasawa M; Murakami H; Nojima Y; Tsukamoto N
Int J Hematol; 2016 Feb; 103(2):219-26. PubMed ID: 26588928
[TBL] [Abstract][Full Text] [Related]
46. Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.
Spunarova M; Tom N; Pavlova S; Mraz M; Brychtova Y; Doubek M; Panovska A; Skuhrova Francova H; Brzobohata A; Pospisilova S; Mayer J; Trbusek M
Leuk Res; 2019 Jun; 81():75-81. PubMed ID: 31054420
[TBL] [Abstract][Full Text] [Related]
47. Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
Vetro C; Haferlach T; Jeromin S; Stengel A; Zenger M; Nadarajah N; Baer C; Weissmann S; Kern W; Meggendorfer M; Haferlach C
Br J Haematol; 2018 Oct; 183(1):47-59. PubMed ID: 30022491
[TBL] [Abstract][Full Text] [Related]
48. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
[TBL] [Abstract][Full Text] [Related]
49. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.
Tausch E; Schneider C; Robrecht S; Zhang C; Dolnik A; Bloehdorn J; Bahlo J; Al-Sawaf O; Ritgen M; Fink AM; Eichhorst B; Kreuzer KA; Tandon M; Humphrey K; Jiang Y; Schary W; Bullinger L; Mertens D; Lurà MP; Kneba M; Döhner H; Fischer K; Hallek M; Stilgenbauer S
Blood; 2020 Jun; 135(26):2402-2412. PubMed ID: 32206772
[TBL] [Abstract][Full Text] [Related]
50.
Pozzo F; Bittolo T; Tissino E; Vit F; Vendramini E; Laurenti L; D'Arena G; Olivieri J; Pozzato G; Zaja F; Chiarenza A; Di Raimondo F; Zucchetto A; Bomben R; Rossi FM; Del Poeta G; Dal Bo M; Gattei V
Haematologica; 2021 Dec; 106(12):3125-3135. PubMed ID: 33121237
[TBL] [Abstract][Full Text] [Related]
51. NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.
Mansouri L; Cahill N; Gunnarsson R; Smedby KE; Tjönnfjord E; Hjalgrim H; Juliusson G; Geisler C; Rosenquist R
Leukemia; 2013 Feb; 27(2):512-4. PubMed ID: 23138133
[No Abstract] [Full Text] [Related]
52. Low-dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long-term outcome from a single center experience.
Sciumè M; Vincenti D; Reda G; Orofino N; Cassin R; Giannarelli D; Gaidano G; Rossi D; Cortelezzi A
Am J Hematol; 2015 Nov; 90(11):970-4. PubMed ID: 26201283
[TBL] [Abstract][Full Text] [Related]
53. Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
Rossi D; Spina V; Bomben R; Rasi S; Dal-Bo M; Bruscaggin A; Rossi FM; Monti S; Degan M; Ciardullo C; Serra R; Zucchetto A; Nomdedeu J; Bulian P; Grossi A; Zaja F; Pozzato G; Laurenti L; Efremov DG; Di-Raimondo F; Marasca R; Forconi F; Del Poeta G; Gaidano G; Gattei V
Blood; 2013 Jun; 121(24):4902-5. PubMed ID: 23637131
[TBL] [Abstract][Full Text] [Related]
54. Distinct immunoglobulin heavy chain variable region gene repertoire and lower frequency of del(11q) in Taiwanese patients with chronic lymphocytic leukaemia.
Huang YJ; Kuo MC; Chang H; Wang PN; Wu JH; Huang YM; Ma MC; Tang TC; Kuo CY; Shih LY
Br J Haematol; 2019 Oct; 187(1):82-92. PubMed ID: 31230372
[TBL] [Abstract][Full Text] [Related]
55. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
56. Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis.
Greco M; Capello D; Bruscaggin A; Spina V; Rasi S; Monti S; Ciardullo C; Cresta S; Fangazio M; Gaidano G; Foà R; Rossi D
Hematol Oncol; 2013 Mar; 31(1):54-5. PubMed ID: 22461140
[No Abstract] [Full Text] [Related]
57. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
58. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
[TBL] [Abstract][Full Text] [Related]
59. Altered DNA Methylation Profiles in
Pacholewska A; Grimm C; Herling CD; Lienhard M; Königs A; Timmermann B; Altmüller J; Mücke O; Reinhardt HC; Plass C; Herwig R; Hallek M; Schweiger MR
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502260
[TBL] [Abstract][Full Text] [Related]
60. Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: clinical and pathogenetic implications.
Wu SJ; Lin CT; Agathangelidis A; Lin LI; Kuo YY; Tien HF; Ghia P
Haematologica; 2017 Jun; 102(6):1085-1090. PubMed ID: 28255015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
